NRIX R&D Expense Growth
Nurix Therapeutics Inc · R&D Expense Growth
NRIX R&D Expense Growth
Latest reported39.04%period ending
NRIX FY R&D Growth (YoY) (0.00% → 39.04%)
Latest values, visible window
High-resolution chart · PNG
NRIX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 39.0426% | |
| 17.1739% | |
| 2.5209% | |
| 58.4563% | |
| 75.1045% | |
| 47.6824% | |
| 11.1344% | |
| 0% |